Conversion to Everolimus in Liver Transplant Patients With Renal Dysfunction

Abstract Calcineurin inhibitor (CNI) immunosuppressive therapy post–liver transplantation (OLT) is important to reduce graft rejection episodes. However, these drugs show important side effects, particularly renal dysfunction (RDF). Changing from CNI to a nonnephrotoxic drug, as mammalian target of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2011-07, Vol.43 (6), p.2307-2310
Hauptverfasser:	Pérez, T, Segovia, R, Castro, L, Roblero, J.P, Estela, R
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Biomarkers - blood Calcineurin Inhibitors Chile Creatinine - blood Drug Substitution Drug Therapy, Combination Everolimus Female Fundamental and applied biological sciences. Psychology Fundamental immunology Glomerular Filtration Rate - drug effects Graft Rejection - immunology Graft Rejection - prevention & control Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Kidney - drug effects Kidney - physiopathology Kidney Diseases - blood Kidney Diseases - chemically induced Kidney Diseases - physiopathology Liver Transplantation - adverse effects Liver Transplantation - immunology Male Medical sciences Middle Aged Pharmacology. Drug treatments Prospective Studies Recovery of Function Sirolimus - administration & dosage Sirolimus - analogs & derivatives Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Time Factors Tissue, organ and graft immunology TOR Serine-Threonine Kinases - antagonists & inhibitors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!